Navigation Links
Biodel Reports Third Quarter Fiscal Year 2011 Financial Results
Date:8/4/2011

DANBURY, Conn., Aug. 4, 2011 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today reported financial results for the third quarter ended June 30, 2011.

Third Quarter Operating Highlights

During Biodel's third quarter of fiscal year 2011, the company:

  • completed Phase 1 testing of two new ultra-rapid-acting formulations of recombinant human insulin, or RHI, for subcutaneous injection;
  • supported investigators at Oregon Health and Sciences University who have initiated a Phase 1 study evaluating these formulations for insulin pump administration;
  • selected multiple analog-based candidate formulations for possible clinical development; and
  • extended the cash runway by reducing near-term RHI purchase requirements and raising approximately $30 million in new capital.

  • Dr. Errol De Souza, president and chief executive officer of Biodel, stated:  "We are continuing to develop and evaluate ultra-rapid-acting human insulin and insulin analog formulations and are making good progress in assessing tolerability and activity in a variety of pre-clinical and clinical settings.  We plan to provide details on the pharmacokinetic, pharmacodynamic and injection site tolerability characteristics of the two RHI-based ultra-rapid-acting formulations from the recently completed subcutaneous injection Phase 1 trial and will update the timelines for completion of the insulin pump trial.  In addition, we have taken a number of steps to extend our cash runway including renegotiation of our RHI supply agreement and raising additional capital from previous and new investors.  These initiatives are helping us create a new generation of ultra-rapid-acting insulin product candidates and sustainable long-term value for all shareholders."

    Third Quarter Financial Results

    Biodel reported a net loss of $4.0 million, or $0.12 per sha
    '/>"/>

    SOURCE Biodel Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. BioDelivery Sciences Announces Completion of BEMA Buprenorphine Phase 3 Chronic Pain Study
    2. Biodel to Raise $30 Million Through Registered Direct Offering
    3. Biodel Inc. to Present at 29th Annual JPMorgan Healthcare Conference on January 13th, 2011
    4. Biodel Announces Name Change for Lead Product Candidate
    5. Dyadic International Reports 2011 Second Quarter Financial Results
    6. Vermillion Reports Results for the Second Quarter 2011
    7. ReportsnReports - Needle-Free Drug Delivery Market & Hospital-Acquired Infections (HAI) Diagnostics Market Reports
    8. Dendreon Reports Second Quarter 2011 Financial Results
    9. Cambrex Reports Second Quarter of 2011 Results
    10. Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma
    11. Gen-Probe Reports Financial Results for the Second Quarter of 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... AUSTIN, Texas , Dec. 24, 2014 /PRNewswire/ ... company focused on gynecologic disease, announced today that ... with investors including Oracle Investment Management, Jack ... Vermillion directors. Total proceeds were $10.5 million, before ... working capital and general corporate purposes. ...
    (Date:12/24/2014)... 23, 2014 “Preparative & Process ... Flash), Consumables (Columns, Solvents, Buffers, Valves, Guages, Seals), ... Agriculture) - Forecasts to 2019” provides a detailed ... current market trends, and strategies impacting the preparative ... and forecasts of the revenue and share analysis. ...
    (Date:12/24/2014)... Earlier this year in a June 24 international ... Adult Stem Cell Technology Center, LLC ( ASCTC ) ... unique property of adult tissue stem cells. His ... the Past, Important for the Future,” embodied the essence ... the address at the 4th World Congress on Cell ...
    (Date:12/24/2014)... 2014 On Friday, December 19, ... the Omnibus and Continuing Resolution Appropriations Act of ... a condition eligible to receive funding through the ... the Department of Defense (DoD). The Hydrocephalus Association ... Capitol Hill, is celebrating this victory for the ...
    Breaking Biology Technology:Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2
    ... his often-quoted book, An Inquiry Into the Nature and Causes ... economic theory that was the 18th century equivalent of todays ... to render the annual revenue of the society as great ... neither intends to promote the public interest, nor knows how ...
    ... this week -- with a one-two punch of an acquisition ... it intends to grow its GE Medical Systems ... the Fairfield, Conn.-based giant to make additional acquisitions in order ... categories it just bought into, according to a company spokesperson. ...
    ... Performance ,Todays business conditions provide a golden opportunity ... for talent might appear to have calmed, the long-term ... tactics to long-term winning strategies. Real competitive advantage ... talent strategy and fundamentally aligning your talent management practice ...
    Cached Biology Technology:Wisconsin Economic Summits have given a hand to states progress 2Wisconsin Economic Summits have given a hand to states progress 3GE Medicals Acquisitions May Prompt More Purchases 2GE Medicals Acquisitions May Prompt More Purchases 3Talent Constellations or Talent Communities Choosing the Right Talent 2Talent Constellations or Talent Communities Choosing the Right Talent 3
    (Date:12/19/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/8kmfcn/iphone_5s ) ... 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire ... http://photos.prnewswire.com/prnh/20130307/600769 ... 2012, Apple introduced the fingerprint reading feature with ... device of Apple incorporating such a feature, called ...
    (Date:12/17/2014)... 2014 The Defense Logistics Agency is ... detect and prevent counterfeit microcircuits from entering into ... started performing an in-house microcircuit anti-counterfeit initiative dubbed ... of purchased microcircuits while increasing their reliability throughout ... will be conducted at DLA,s Electronics Product Test ...
    (Date:12/15/2014)... 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is ... Facial recognition system measures the overall facial feature ... mouth, and the distance between eyes. Facial recognition ...
    Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
    ... in research to support energy efficiency policy and contribute to ... was unveiled today. Five new End Use Energy ... of energy use across society and how energy can be ... 26 million funding from two research councils, the Engineering and ...
    ... broad genetic landscape mapped of a Burkitt lymphoma tumor, ... mutations, including several that had not previously been associated ... to the disease. Findings from the genetic sequencing ... be used to develop new drugs or aim existing ...
    ... infectious diseases of humans come from animals. International health ... humans and livestock, not for companion dogs and cats. ... monitor infectious diseases of companion dogs and cats. The ... the School of Veterinary Sciences at the University of Bristol ...
    Cached Biology News:£39 million for UK energy efficiency research to cut carbon use 2£39 million for UK energy efficiency research to cut carbon use 3£39 million for UK energy efficiency research to cut carbon use 4Duke Medicine news -- Genome sequencing of Burkitt Lymphoma reveals unique mutation 2Call for global monitoring of infectious diseases in dogs and cats 2
    ... ISO 9001:2000 Certified USDA Research Registered OLAW ... Training AALAS Certified Technicians ... GLP Documentation Upon Request Focus ... for all your custom immunology service needs. ...
    ...
    Applications: Western blotting ...
    ...
    Biology Products: